influenza A viruses was estimated at 96%, we assumed that for any given week and in any country all influenza virus A detections were A (H1N1). Therefore, the number of specimens analyzed and the number of specimens with influenza virus A were included in the analysis.
The third dataset used was weekly susceptibility data of influenza viruses A (H1N1) for oseltamivir derived from sentinel and nonsentinel (e.g., from hospital or peripheral laboratories) sources combined, based on the week the clinical specimens were taken. The number of influenza viruses A (H1N1) analyzed and the number of oseltamivir-resistant influenza viruses A (H1N1) were included in the analysis. Because the European crude proportion of resistant influenza viruses A (H1N1) among the tested influenza viruses A (H1N1) was similar between viruses from sentinel and nonsentinel sources, no distinction was made between sentinel and nonsentinel viruses to estimate the fraction of patients with resistant influenza virus A (H1N1) per number of patients with A virus (H1N1) tested for resistance.
A fourth dataset was used to model the correction of viral diagnosis data based on specimens collected from ARI patients to diagnosis data on the basis of specimens collected from patients with ILI. This fourth dataset was collected in the Dutch sentinel surveillance during 3 subsequent seasons (ARI-EL study), 2000-01, 2001-02, and 2002-03, and consisted of consultation rates for ILI and acute respiratory tract infections other than ILI (ARTI) and virus detections in specimens collected from patients with ILI or ARTI (1) .
Countries were excluded from the modeling if >1 of the first 3 datasets described above were missing. In the first dataset, these were Croatia, Cyprus, Finland, Malta, Turkey, and Ukraine; in the second, Cyprus and Turkey; and in the third, Cyprus, Lithuania, and Malta.
Methods and Results
Calculation of an average prevalence would have been relatively simple if for each week all datasets were complete for each country. However, only limited data are available. Especially at the beginning and end of the season, data are missing. These missing data occur, for example, in the number of patients with ILI or ARI, in the number of specimens tested for influenza virus detection and subtype determination, and especially in the number of influenza viruses A (H1N1) tested for oseltamivir resistance. To correct for these missing data, a modeling approach was used.
For the weighting procedure, a target population must be identified first. For example, it is not correct to weight directly with the number of inhabitants of a country because not every person is infected. The target population is identified as follows. A fraction of the total population of a country is covered by the sentinel physicians. This population is divided into "ILI" and "non-ILI" groups. The ILI population is the first part of the target population. From a fraction of the ILI sentinel population, specimens are tested for influenza virus. This population is divided into "influenza A" and "non-influenza A" groups. The influenza A population is the second part of the target population, so the target population is ILI patients who are infected with influenza A virus. Within this target population, from a limited number of persons, the virus is tested for resistance; this fraction varies largely by country and week. We assume that sentinel data are representative of the whole population in a country, that all influenza viruses A are A (H1N1), and that the prevalence of resistance among tested A viruses (H1N1) does not depend on testing of sentinel or nonsentinel specimens. Hence, a total of 3 fractions have to be modeled:
"ILI per population covered," "influenza A sentinel per specimens sentinel," and "A (H1N1) resistant per A (H1N1) tested."
The used model is a so-called mixed effect logistic regression model (2, 3) . This model allows modeling of binomial proportions, i.e., a numerator and a denominator as a function of time:
For country i at time j the number of cases y i,j comes from a binomial distribution with parameters n i,j , the denominator, and p i,j , the proportion. The log-odds are parametric functions of time, where the parameters b 0,i , …, b 3,i themselves come from a multivariate normal distribution (here, 4 parameters). As a result, each country has its own parameters that vary around a mean value β 0 , …, β 3 : The advantage of such an approach is that it smartly combines data from all countries.
The larger the denominator, the more information an observation provides to the estimation of b.
As a consequence, if there are no observations, or the denominator is small, the fit will shrink to its mean value β, and uncertainties increase. Using this modeling approach, estimating the weekly prevalences still is possible, even if there are no observations.
For the countries collecting ARI clinical data, the fractions "ARI per population covered"
were pragmatically converted to "ILI per population covered" by multiplying the results by a modeled weekly fraction ILI/ARI for a "mean" country on the basis of data from countries with both weekly clinical ILI and ARI sentinel surveillance data (Belgium, Czech Republic, Estonia, Latvia, Lithuania, Luxembourg, Romania, Slovakia, and Slovenia). The fraction "influenza A sentinel/specimens sentinel" for the countries collecting virus detection data from patients with ARI were pragmatically converted to ILI by multiplying the results by a modeled weekly factor for a mean influenza season, based on the Dutch ARI-EL dataset (1) . 
